How to Succeed in Ophthalmology Residency

Pavlina Kemp, MD; Samuel Tadros, MD; Blake K. Williamson, MD, MPH; and Gary Wörtz, MD

Eyetube

Blake Williamson, MD, MPH, and Gary Wörtz, MD, return for a new season of Ophthalmology off the Grid! This season, the hosts dive into the basics of training and education at the most prestigious programs in ophthalmology across the United States. In this episode, they invite Pavlina Kemp, MD, residency program director at the University of Iowa Department of Ophthalmology and Visual Sciences, and Samuel Tadros, MD, a PGY-4 ophthalmology resident, to share a state of the union on ophthalmology residency. They discuss what it takes to stand out during the application and interviewing process and find success in the field.

Ocular Syphilis: the Great Imitator

Learn some of the different ways this increasingly common disease can present and proven ways to manage it.

Connor Kortright, OD

Modern Optometry

Ocular syphilis, often dubbed the great imitator because it can present as several other conditions, continues to challenge clinicians with its diverse and often misleading presentations. With incidence rates rising annually,1 optometrists are increasingly likely to encounter this elusive disease in practice. In my home state of New York, new cases of syphilis have steadily increased to reach more than 10,000 in 2022, after essentially no new cases were reported in 2000.2 This article presents five cases that show the diverse presentations of ocular syphilis and just how difficult it can be to detect this tricky, and increasingly common, disease. CASE NO. 1: A MISDIAGNOSED KERATITIS A 33-year-old Black man presented with bilateral eye pain persisting for 1 month.3 It was initially treated as conjunctivitis by a previous provider. He had a pustular facial rash, and his vision was reduced to 20/70 OD and 20/60 OS. Examination revealed bilateral peripheral ulcerative keratitis. Workup later confirmed syphilis infection with HIV coinfection. The patient was initially treated with steroids but was transitioned to 4 million units of intravenous (IV) penicillin every 4 hours for 14 days after confirmation of syphilis infection, leading to remarkable visual recovery (20/20 OU). CASE NO.

Alcon and Lensar Call Off Merger

Eyetube

Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices